false 1 January 2024 OC390124 2024-01-01 2024-12-31 OC390124 2023-12-31 OC390124 2024-12-31 OC390124 frs102-bus:FRS102 2024-01-01 2024-12-31 OC390124 frs102-bus:LimitedLiabilityPartnershipLLP 2024-01-01 2024-12-31 OC390124 frs102-bus:FullAccounts 2024-01-01 2024-12-31 OC390124 frs102-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 OC390124 2023-01-01 2023-12-31 OC390124 2022-12-31 OC390124 2023-12-31 OC390124 frs102-core:CurrentFinancialInstruments 2024-12-31 OC390124 frs102-core:CurrentFinancialInstruments 2023-12-31 OC390124 frs102-bus:Director1 2024-01-01 2024-12-31 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares
Registered number:
OC390124
Europe Medical Treat LLP
Unaudited Accounts
for the Year Ended
31 December 2024


Europe Medical Treat LLP
Balance Sheet
as at 31 December 2024

Notes 2024
£
2023
£
Current Assets
Debtors 1,409,376 915,981
Cash at bank and in hand 33,376 45,939
1,442,752 961,920
Creditors falling due within one year (229,649) (107,649)
Net Current Assets / (Liabilities) 1,213,103 854,271
Net Assets Attributable to Members 1,213,103 854,271
Represented by:
Loans and other debts due to members within one year
Members' capital classified as a liability 3 1,213,103 854,271
1,213,103 854,271
.
Members' other interests
1,213,103 854,271
.
Total members' interests
Loans and other debts due to members 1,213,103 854,271
1,213,103 854,271

Europe Medical Treat LLP
Balance Sheet
as at 31 December 2024



These accounts have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

The members have not delivered a copy of the LLP's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006 (as applied to LLPs).

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 (as applied to LLPs) with respect to accounting records and the preparation of accounts.

For the year ended 31 December 2024 the LLP was entitled to exemption under section 477 of the Companies Act 2006 (as applied to LLPs) relating to small LLPs.

The financial statements were approved by the members and signed on their behalf by:



.........................................................


Approved by members on 22 September 2025


Mr C M Teler

Designated Member

Europe Medical Treat LLP

Registered number: OC390124 (England and Wales)


Europe Medical Treat LLP
Notes to the Accounts
for the year ended 31 December 2024

1. Accounting Policies

Basis of preparation

These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, the Companies Act 2006 and the Statement of Recommended Practice "Accounting by Limited Liability Partnerships".

These financial statements reflect the results of the LLP for the year ended 31 December 2024.

Tax provisions

Taxation on the profits of the LLP is solely the liability of individual members. Therefore, neither income tax nor deferred tax arising in respect of the LLP's profit is included in these financial statements.
2. Employees
2024 2023
Average number of employees during the period 0 0

3. Members' Interests
Other reserve Net loans & other debts due to members Total
2024
Total
2023
£ £ £ £
Brought Forward 1,212,734 (358,463) 854,271 405,360
Profit (loss) for period available for discretionary
division among members
363,794 - 363,794 448,911
Members' interest after profit (loss) for period 1,576,528 (358,463) 1,218,065 854,271
Other divisions of profits (losses) - - - -
Less: Drawings - (4,962) (4,962) -
Balance carried forward 1,576,528 (363,425) 1,213,103 854,271